848952-39-6 Usage
General Description
2-Methyl-3-hydroxy-6-iodopyridine is a chemical compound with the molecular formula C6H6INO. It is a derivative of pyridine, with a methyl group and a hydroxyl group attached to the 2 and 3 positions, respectively, and an iodine atom at the 6 position. 2-Methyl-3-hydroxy-6-iodopyridine is often used as a building block in organic synthesis, particularly in the pharmaceutical industry for the preparation of various drugs and drug intermediates. It is also used as a reagent in chemical research and can undergo various chemical reactions such as alkylation, arylation, and halogenation, making it a versatile chemical for the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 848952-39-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,9,5 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 848952-39:
(8*8)+(7*4)+(6*8)+(5*9)+(4*5)+(3*2)+(2*3)+(1*9)=226
226 % 10 = 6
So 848952-39-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H6INO/c1-4-5(9)2-3-6(7)8-4/h2-3,9H,1H3
848952-39-6Relevant articles and documents
CSF1R INHIBITORS FOR USE IN TREATING CANCER
-
Paragraph 0147, (2020/07/15)
Described herein are CSF1R inhibitors for use in methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT).
AZAARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF FOR USE IN PHARMACY
-
Paragraph 0083-0085, (2020/04/21)
An azaaryl derivative with the structure of formula (I), a preparation method therefor and a pharmaceutical use thereof are disclosed in the present invention. The series of compounds of the present invention can be widely applied in the preparation of dr
BIARYL KINASE INHIBITORS
-
Page/Page column 185, (2017/05/07)
The present disclosure is directed to biaryl compounds of formula (I) which can inhibit AAKl (adaptor associated kinase 1), compositions comprising such compounds and their use for treating e.g. pain, Alzheimer's disease, Parkinson's disease and schizophrenia.
